M11.171 Familial chondrocalcinosis, right ankle and foot

Name of the Condition

• Familial chondrocalcinosis, right ankle and foot

Summary

Familial chondrocalcinosis, right ankle and foot is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the joint tissues of the right ankle and foot. This leads to inflammation, pain, and potential joint damage. It is a subtype of calcium pyrophosphate deposition disease (CPPD) with a genetic basis, often presenting with recurrent joint symptoms in the affected area. Diagnosis relies on clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, right ankle and foot is caused by genetic mutations that predispose individuals to abnormal calcium pyrophosphate crystal formation in the cartilage, synovium, or periarticular structures of the right ankle and foot. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Genetic predisposition (family history of chondrocalcinosis or related crystal arthropathies).
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Ankle or foot trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Pain, swelling, and stiffness in the right ankle and foot.
• Recurrent episodes of acute inflammation.
• Reduced range of motion in the affected joints.
• Possible joint deformity over time.

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history (including family history), and imaging studies (e.g., X-rays, ultrasound, or MRI) to detect crystal deposition or joint changes. Joint fluid analysis may be performed to identify CPPD crystals under polarized light microscopy. Blood tests or genetic testing may be used to assess metabolic or hereditary factors.

Treatment Options

Treatment focuses on managing symptoms and reducing inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine may be used for acute episodes. Intra-articular corticosteroid injections can provide targeted relief. Physical therapy helps maintain joint function. Long-term management may include lifestyle modifications and monitoring for joint damage.

Prognosis and Follow-Up

Prognosis varies depending on the extent of joint involvement and response to treatment. Recurrent episodes of inflammation are common, but joint damage can be minimized with appropriate management. Regular follow-up with a healthcare provider is recommended to monitor symptoms, adjust treatment, and address complications.

Complications

• Chronic joint pain and stiffness.
• Progressive joint damage or osteoarthritis.
• Reduced mobility or functional impairment.
• Rarely, crystal deposition in other joints.

Lifestyle & Prevention

• Maintain a healthy weight to reduce joint stress.
• Avoid activities that strain the ankle or foot.
• Use supportive footwear to stabilize the affected joints.
• Follow prescribed treatment plans to manage inflammation.
• Stay active with low-impact exercises to preserve joint function.

When to Seek Professional Help

Seek medical attention if you experience persistent pain, swelling, or stiffness in the right ankle or foot, especially if symptoms worsen or interfere with daily activities. Acute episodes of severe inflammation or inability to bear weight on the affected limb also warrant prompt evaluation.

Tips for Medical Coders

This code (M11.171) specifies familial chondrocalcinosis affecting the right ankle and foot. Documentation should clearly indicate the hereditary nature of the condition and the specific site (right ankle and foot) to support accurate coding. Ensure clinical notes include details about crystal deposition, joint involvement, and any diagnostic findings (e.g., imaging or fluid analysis) to confirm the diagnosis.